Anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngeneic mice bearing bladder cancer

杨登科; 靳风烁

您当前的位置：

首页 >

文章列表页 >

Anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngeneic mice bearing bladder cancer

更新时间：2026-01-09

- Anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngeneic mice bearing bladder cancer
- Journal of Army Medical University Vol. 29, Issue 18, Pages: 1772-1775(2007)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-362;R730.23;R737.14
- Published：2007
- 稿件说明：
移动端阅览
杨登科,靳风烁.分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌抑癌效应的研究[J].陆军军医大学学报(原第三军医大学学报),2007,29(18):1772-1775.

　YANG Deng-ke,JIN Feng-shuo.Anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngeneic mice bearing bladder cancer[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(18):1772-1775.
杨登科,靳风烁.分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌抑癌效应的研究[J].陆军军医大学学报(原第三军医大学学报),2007,29(18):1772-1775. DOI：

　YANG Deng-ke,JIN Feng-shuo.Anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngeneic mice bearing bladder cancer[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(18):1772-1775. DOI：

摘要

目的探讨分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌的抑癌效应。方法采用小鼠T

739

可移植性膀胱癌模型，共80只分为10组，于移植瘤处局部注射分枝杆菌Ag85B/IL-2融合蛋白，并用Ag85B蛋白、BCG、IL-2和生理盐水作对照，观察治疗后各组的肿瘤质量、体积和存活期。光镜和电镜下观察肿瘤的形态改变。结果分枝杆菌Ag85B/IL-2融合蛋白治疗组小鼠肿瘤瘤质量（2.49±0.60） g，非常显著低于Ag85B蛋白组、BCG组、IL-2组和生理盐水组（P0.01）；Ag85B/IL-2融合蛋白治疗组小鼠肿瘤瘤体积（3.01±0.95）cm

，显著低于Ag85B蛋白组、BCG组、IL-2组和生理盐水组（P0.05，P0.01）；Ag85B/IL-2融合蛋白治疗组小鼠存活天数（35.50±2.60） d，显著长于Ag85B蛋白组，BCG组、IL-2组和生理盐水组（P0.05，P0.01）；Ag85B/IL-2融合蛋白对小鼠的肿瘤质量抑制率为64.50％，肿瘤体积抑制率为62.24％，存活延率为48.66％。光镜下观察Ag85B/IL-2融合蛋白治疗组肿瘤细胞有明显的炎性细胞浸润、肿瘤细胞坏死、出血等改变；透射电镜下观察，可见细胞膜破裂，细胞器破坏，细胞质固缩，细胞核破坏，核染色质聚集，凋亡小体出现，巨噬细胞吞噬增多等现象。结论分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌具有抑制作用，并能延长膀胱癌荷瘤鼠的生存期。

Abstract

Objective To study the anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngenic mice bearing bladder cancer. Methods After being implanted BTT739 bladder transitional carcinoma cells from tumor bearing mice

80 T739 mice were divided into Ag85B protein

BCG

IL-2 and normal saline groups (n=20). Mycobacterium Ag85B/IL-2 protein was locally injected to the mice at the site of implanting tumor in the trial group

and Ag85B protein

BCG

IL-2 and normal saline to the control group mice. The weight and volume of tumor and the survival period were recorded after treatment. Results The average weight of Ag85B/IL-2 fusion protein treatment group was significantly lower than those of Ag85B

BCG，IL-2 and normal saline group （P0.01）. The average volume of Ag85B/IL-2 fusion protein treatment group was significantly lower than those of Ag85B

BCG，IL-2 and normal saline group （P0.05

P0.01）. The average survival period of Ag85B/IL-2 fusion protein treatment group was significantly longer than those of Ag85B

BCG，IL-2 and normal saline group （P0.05

P0.01）. The tumor weight and volume inhibition rate of Ag85B/IL-2 fusion protein were 64.50％ and 62.24％

respectively

and the survival period prolonging rate of Ag85B/IL-2 fusion protein was 48.66％. Under light microscope

the bladder tumor tissue treated by Ag85B/Il-2 presented obviously inflammatory cells infiltrating

neoplasm necrosis

hemorrhage. With transmission electron microscope

the bladder tumor cell membrane was un-integrated

organelles damaged

cytoplasm pycnosis

nucleus fragmentation

aggregation on chromatin

apoptosis body coming up

macrophage swollen and so on. Conclusion The results indicate that mycobacterium Ag85B/IL-2 protein has obvious anti-tumor effect in T739 mice bearing bladder cancer and can prolong its survival period.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Inhibitory effect of doxorubicin-loaded mesoporous silica nanoparticles on bladder cancer cells

Anti-tumor effect of mitochondrial targeted small molecule IR-780 on cisplatin-resistant bladder cancer cells

M2 macrophages promotes bladder cancer EMT through CLDN10 involved signaling pathway in tumor micro-environment

Role of 8-autophagy-related long non-coding RNAs signature in prognosis for bladder cancer

Starvation microenvironment activates Yes-associated protein 1 to regulate autophagy and promote proliferation of bladder cancer cells

Related Author

Qiaoling SU

Heping QIU

Jinjin LI

Yuandi HUANG

Qiang FANG

Yi ZHI

Weibing LI

Yuandi HUANG

Related Institution

Department of Urology, the Third Affiliated Hospital of Chongqing Medical University

Department of Urology, Chongqing University Cancer Hospital

Center for Health Examination and Cancer Risk Screening, Chongqing University Cancer Hospital

Department of Urology, Sun Yat-sen University Cancer Center

Department of Urology, the First Affiliated Hospital of Chongqing Medical University

⁰